Bridging the academia-to-industry gap: organ-on-a-chip platforms for safety and toxicology assessment

Terry Ching,Yi-Chin Toh,Michinao Hashimoto,Yu Shrike Zhang
DOI: https://doi.org/10.1016/j.tips.2021.05.007
IF: 17.638
2021-09-01
Trends in Pharmacological Sciences
Abstract:Some organ-on-a-chip (OoC) systems for drug evaluation show better predictive capabilities than planar, static cell cultures and animal models. One of the ongoing initiatives led by OoC developers is to bridge the academia-to-industry gap in the hope of gaining wider adoption by end-users – academic biological researchers and industry. We discuss several recommendations that can help to drive the adoption of OoC systems by the market. We first review some key challenges faced by OoC developers before highlighting current advances in OoC platforms. We then offer recommendations for OoC developers to promote the uptake of OoC systems by the industry.
pharmacology & pharmacy
What problem does this paper attempt to address?